ExploreWatchlistsPricing
  1. JP-listed companies
  2. Immuno-Biological Laboratories Co., Ltd.
  3. Financials
  4. Net income margin (%)

Immuno-Biological Laboratories Co., Ltd. (4570)

Market cap
¥14.1B
P/E ratio
53.1x
Develops antibody-based diagnostic tools and testing services for medical research, plus manufactures cosmetics using human-type collagen from silkworms.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndNet income margin (%) YoY (%)
Mar 31, 202525.7+12.37%
Mar 31, 202422.9-162.69%
Mar 31, 2023-36.5-8.75%
Mar 31, 2022-40-24.46%
Mar 31, 2021-52.9-54.34%
Mar 31, 2020-115.9+440.93%
Mar 31, 2019-21.4+208.54%
Mar 31, 2018-6.9-97.54%
Mar 31, 2017-282.5+6254.83%
Mar 31, 2016-4.4-79.55%
Mar 31, 2015-21.7+15.18%
Mar 31, 2014-18.9-198.64%
Mar 31, 201319.1+308.93%
Mar 31, 20124.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat